Zobrazeno 1 - 10 of 131 pro vyhledávání: '"H.G. Mertens"'
1
Panencephalopathic Type of Creutzfeldt-Jakob Disease with Primary Extensive Involvement of White Matter
Autor: C. Meesmann, J. Müller, H. Krüger, E.R. Rohrbach, H.G. Mertens
Publikováno v: European Neurology. 30:115-119
The case of a 66-year-old woman with atypical Creutzfeldt-Jacob disease (CJD) presents several peculiarities. Pathologic examination confirmed a rare CJD case with primary generalized spongiform changes of the white matter and only moderate, but typi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0206d0a0869925062934091f28014b3
https://doi.org/10.1159/000117324
Zobrazit plný text záznamu
3
Polyneuropathy and Stiff-man Syndrome
Autor: K. Ricker, G. Paal, H.G. Mertens
Publikováno v: European Neurology. 5:11-24
A 49-year-old female patient developed a syndrome of diffuse muscular rigidity associated with the symptoms of a mild polyradiculitis. The muscular rigidity was differentiated from
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e45b03464f8cf4da0cb16505fcbd053e
https://doi.org/10.1159/000114056
Zobrazit plný text záznamu
4
Therapie chronisch-hypoglykorrhagischer Meningitiden
Autor: F. von Baumgarten, G. Krichenbauer, S. Bittkau, H. Przuntek, K. Höhnke, H.G. Mertens, A. Burkhard
Publikováno v: Verhandlungen der Deutschen Gesellschaft für Neurologie ISBN: 9783540182542
Die chronische hypoglykorrhagische Meningitis, definiert als chronische Meningitis mit erhohter Leukozytenzahl im Liquor cerebrospinalis, erhohtem Liquoreiweis und erniedrigtem Liquorzucker, kommt selten vor.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fefc54f939cec87265d28ceda87157f8
https://doi.org/10.1007/978-3-642-83201-7_151
Zobrazit plný text záznamu
5
Aprotinin Versus Tranexamic Acid in Antifibrinolytic Treatment of Patients with Subarachnoid Hemorrhage
Autor: H.G. Mertens, H. Przuntek, G. Burkard, F. J. von Baumgarten, D. Englert
Publikováno v: Verhandlungen der Deutschen Gesellschaft für Neurologie ISBN: 9783540182542
Adams et al. (1) showed, in a study of 4700 patients, that the rebleeding rate during the first 14 days after hemorrhage could be reduced from 20% to 7% by antifibrinolytic treatment with epsilon-aminocaproicacid or tranexamic acid. Fodstadt et al. (
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3c03423cd4475bb993430ff94eb0733c
https://doi.org/10.1007/978-3-642-83201-7_111
Zobrazit plný text záznamu
6
Treatment of vasospasm due to subarachnoid hemorrhage with calcium entry blockers
Autor: F.v. Baumgarten, H.G. Mertens, H. Przuntek
Publikováno v: European neurology. 25
Cerebral vasospasm is the most important factor causing neurological deterioration later than 72 h after subarachnoid hemorrhage (SAH). The few clinical studies investigating the effect of calcium entry blockers on SAH demonstrate that patients treat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbcccb83f6e2e07194236a135da79592
https://pubmed.ncbi.nlm.nih.gov/3530777
Zobrazit plný text záznamu
7
Local hemostasis in subarachnoid hemorrhage
Autor: G. Burkhard, F.J. von Baumgarten, H.G. Mertens, H. Przuntek, P. H. Kraus, D. Englert, G. Müller-Berghaus
Publikováno v: European neurology. 27(3)
Fibrinopeptide A (FPA), platelet-secreted protein, platelet factor 4 and beta-thromboglobulin were determined in the cerebrospinal fluid of patients who had suffered from subarachnoid hemorrhage and were treated with 6 g tranexamic acid or 4 million
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25f95192852a0f4762888728a0d6adce
https://pubmed.ncbi.nlm.nih.gov/2957204
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje